Partnerships

AIM is proud to partner and support nonprofits and academic institutions, community groups, public health agencies, government, and corporate allies in the private sector to help achieve AIM’s mission of…

All Resources and Tools

AIM provides resources to support the work of public health leaders in immunization program management, education, and public health advocacy. Search for specific resources by keyword, or simply click "search"…

AIM In the News: The Washington Post

Executive Director Claire Hannan was featured in an article by The Washington Post detailing the CDC’s preferential recommendation of mRNA Pfizer and Moderna COVID-19 vaccine and booster shots over the Johnson & Johnson COVID-19 vaccine.

Updated COVID-19 Vaccine Booster Doses

Learn more about the two new Omicron (bivalent) vaccines, Pfizer and Moderna, which were recently authorized to be used as booster doses to help protect against the Omicron variants of the virus that causes COVID-19.

FDA Authorized vs FDA Approved

This talking points document was developed by iREACH Subject Matter Experts Dr. Yabo Beysolow and Lisa Jacques-Carroll to provide information on the difference between vaccines that have been authorized by the FDA vs. approved by the FDA.

Chicago: Healthy Chicago Equity Zones

This 2022 Bull's-Eye Award Winner targeted populations hardest hit by COVID-19 through programs overseen by the Healthy Chicago Equity Zones (HCEZ) program.

Back To Top
Search